Skip to main content

Evidence-Based Practices

David Gastfriend, MD, DFASAM, explained to NCAD attendees how technology platforms can help providers overcome obstacles to adopting contingency management programs that have been proven to effectively augment traditional treatment modalities.
At NCAD, Kevin McCauley, MD, explained to NCAD attendees how, much like aviation safety checklists help Navy pilots avoid mishaps, recovery plans protect individuals in addiction treatment stay sober when they otherwise might struggle to make proper decisions.
Although many treatment centers are under-resourced, Jamie Marich, PhD, LPCC-S, LICDC-CS, REAT, RYT-200, said in her NCAD session that trauma must be addressed as a root cause of many addiction disorders.
The Foundation for Opioid Response and New York Community Trust are providing $750,000 to Housing Works for a program that aims to improve high-risk populations’ retention and adherence to medications for opioid use disorder.
Braeburn has requested final approval from the U.S. Food and Drug Administration for Brixadi, an injectable form of buprenorphine with weekly and monthly formulations.
Walter Miley and Mary Woods of WestBridge speak about what differentiates WestBridge's care plans as they tackle the challenge of integrated treatment. By focusing and honing care plans to meet the…
Back to Top